449 related articles for article (PubMed ID: 18817982)
1. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the canine cytokine TWEAK (CD255) and its receptor, Fn14 (CD266).
Zhang JX; Sang M; Zhao W; Ai HX; Shui Y; Li JF; Song R; Zhang SQ
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):172-5. PubMed ID: 20452679
[TBL] [Abstract][Full Text] [Related]
3. Molecular structure and characterization of the cytokine TWEAK and its receptor Fn14 in bovine.
Zhang JX; Sang M; Li JF; Zhao W; Ma HW; Min C; Hu YL; Du MX; Zhang SQ
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):238-46. PubMed ID: 21955444
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
6. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
7. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
8. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
[TBL] [Abstract][Full Text] [Related]
10. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
12. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
[TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
Yepes M; Winkles JA
Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
[TBL] [Abstract][Full Text] [Related]
17. Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization.
De A; Park JI; Kawamura K; Chen R; Klein C; Rauch R; Mulders SM; Sollewijn Gelpke MD; Hsueh AJ
Mol Endocrinol; 2006 Oct; 20(10):2528-38. PubMed ID: 16762976
[TBL] [Abstract][Full Text] [Related]
18. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
[TBL] [Abstract][Full Text] [Related]
19. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]